MBOT Profile
Microbot Medical Inc., a pre-clinical medical device company, is at the forefront of advancing robotic technologies for minimally invasive surgery. The company focuses on the research, design, and development of innovative endoluminal surgery devices, aiming to improve patient outcomes and surgical precision. Microbot Medical's product portfolio includes several cutting-edge micro-robotic technologies, such as ViRob, TipCAT, CardioSert, and Liberty, each designed to address specific medical needs.
Among its key developments is the Self Cleaning Shunt, designed to treat hydrocephalus and normal pressure hydrocephalus by preventing shunt blockage and reducing the need for surgical interventions. Additionally, the company is working on a disposable robotic system for various endovascular interventional procedures, enhancing the flexibility and efficiency of minimally invasive treatments. The company also has a multi-generation pipeline of technologies aimed at expanding its impact in the field of robotic surgery.
Microbot Medical holds a significant intellectual property portfolio, with 42 issued or allowed patents and 23 pending patent applications worldwide. This robust patent portfolio underscores the company’s commitment to innovation and its competitive position in the medical device industry. The company’s strategic initiatives are further bolstered by a collaboration agreement with Stryker Corporation, aimed at co-developing advanced technologies and accelerating the commercialization of its products.
Founded in 2010 and headquartered in Hingham, Massachusetts, Microbot Medical Inc. has established itself as a pioneer in robotic surgery technology. Its dedication to developing transformative solutions for minimally invasive procedures reflects its role in shaping the future of medical robotics and improving surgical outcomes for patients globally.
|
